Oncolytics Biotech Inc. appointed Matt Coffey as president and CEO, effective immediately.
Coffey was named the company's interim president and CEO in November 2016.
Discover more about S&P Global’s offerings
Oncolytics Biotech's interim CEO to head company on a permanent basis
Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders
Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps
Oncolytics Biotech Inc. appointed Matt Coffey as president and CEO, effective immediately.
Coffey was named the company's interim president and CEO in November 2016.